Figure 1From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study The incidence and magnitude of allogeneic blood product transfusions. RBC: Red blood cells; FFP: Fresh frozen plasma; PLT: Platelets.Back to article page